5757-66-4 Usage
General Description
4-bromo-2,6-dimethylbenzenecarbonitrile is a chemical compound with the molecular formula C10H9BrN. It is a nitrile derivative of 2,6-dimethylphenyl bromide, and its structure consists of a benzene ring with two methyl groups and a bromine atom, as well as a nitrile functional group attached to the benzene ring. 4-bromo-2,6-dimethylbenzenecarbonitrile is commonly used as a precursor in the synthesis of various organic compounds, including pharmaceuticals, agrochemicals, and dyes. It is also utilized as an intermediate in the production of specialty chemicals and is known for its applications in organic synthesis and research. Additionally, 4-bromo-2,6-dimethylbenzenecarbonitrile is considered to be a versatile building block in the field of organic chemistry, making it an important compound for many industries.
Check Digit Verification of cas no
The CAS Registry Mumber 5757-66-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,5 and 7 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5757-66:
(6*5)+(5*7)+(4*5)+(3*7)+(2*6)+(1*6)=124
124 % 10 = 4
So 5757-66-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H8BrN/c1-6-3-8(10)4-7(2)9(6)5-11/h3-4H,1-2H3
5757-66-4Relevant articles and documents
The application of NCTS (N-cyano-N-phenyl-p-toluenesulfonamide) in palladium-catalyzed cyanation of arenediazonium tetrafluoroborates and aryl halides
Li, Jizhen,Xu, Wenbin,Ding, Junshuai,Lee, Kuo-Hsiung
supporting information, p. 1205 - 1209 (2016/03/01)
Using NCTS (N-cyano-N-phenyl-p-toluenesulfonamide) as an electrophilic cyanation reagent, palladium-catalyzed cyanation of arenediazonium tetrafluoroborates and aryl halides was achieved under mild conditions. The method allowed the effective synthesis of various aryl nitriles in suitable yields via a coupling reaction.
NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS
-
Page/Page column 96, (2010/09/07)
This invention relates to novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy.
HYDRAZIDES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS - 681
-
Page/Page column 25-26, (2008/12/08)
The present invention is directed to compounds of Formula I: wherein A and R1 to R8 are as defined in the specification.